Security Snapshot

Teladoc Health, Inc. - Common Stock (TDOC) Institutional Ownership

CUSIP: 87918A105

13F Institutional Holders and Ownership History from Q2 2015 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

319

Shares (Excl. Options)

142,252,104

Price

$5.45

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+10,505,019
Value change
+$44,606,028
Number of holders
319
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
178,397,403
SEC-reported price per share
$6.79
Insider filing price
$6.79
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • TDOC - Teladoc Health, Inc. - Common Stock is tracked under CUSIP 87918A105.
  • 319 institutions reported positions in Q1 2026.
  • 4 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 337 to 319 between Q4 2025 and Q1 2026.
  • SEC-reported value moved from $925,457,583 to $775,659,816.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 319 institutions filings for Q1 2026.

Open SEC evidence

Security key

87918A105

Latest holder period

Q1 2026

13F holders

319

13D/G owners

4

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
4
Security
TDOC
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 7.8% $99,368,053 13,556,351 BlackRock, Inc. 31 Mar 2025
VANGUARD PORTFOLIO MANAGEMENT LLC 7% $67,859,400 12,451,266 Vanguard Portfolio Management 31 Mar 2026
VANGUARD CAPITAL MANAGEMENT LLC 5.2% $50,168,918 9,205,306 Vanguard Capital Management 31 Mar 2026
Point72 Asset Management, L.P. 3.3% -34% $44,796,726 -$23,430,960 5,795,178 -34% Point72 Asset Management, L.P. 30 Sep 2025

As of 31 Mar 2026, 319 institutional investors reported holding 142,252,104 shares of Teladoc Health, Inc. - Common Stock (TDOC). This represents 80% of the company’s total 178,397,403 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
62%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 8.2% 14,613,556 +2.5% 0% $79,643,883
VANGUARD PORTFOLIO MANAGEMENT LLC 6.9% 12,295,094 0% 0% $67,008,262
RENAISSANCE TECHNOLOGIES LLC 4.5% 8,085,542 +1.3% 0.07% $44,066,204
VANGUARD CAPITAL MANAGEMENT LLC 4.4% 7,857,169 0% 0% $42,821,571
Point72 Asset Management, L.P. 4.3% 7,721,495 +36% 0.07% $42,082,148
DIMENSIONAL FUND ADVISORS LP 3.5% 6,298,405 -16% 0.01% $34,322,646
Allianz Asset Management GmbH 2.7% 4,791,363 +54% 0.03% $26,112,928
STATE STREET CORP 2.4% 4,359,751 +2.6% 0% $23,760,643
Voss Capital, LP 2.4% 4,200,000 1.3% $22,890,000
GEODE CAPITAL MANAGEMENT, LLC 2.3% 4,180,484 -0.19% 0% $22,788,286
Monaco Asset Management SAM 2.3% 4,030,156 +106% 7% $21,964,350
AMERICAN CENTURY COMPANIES INC 1.9% 3,456,384 +12% 0.01% $18,837,293
Pale Fire Capital SE 1.9% 3,398,491 +75% 1.6% $18,521,776
JUPITER ASSET MANAGEMENT LTD 1.7% 3,109,714 -19% 0.09% $16,947,941
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.7% 3,037,974 +19% 0% $16,556,958
Man Group plc 1.7% 3,021,550 +86% 0.03% $16,467,448
GOLDMAN SACHS GROUP INC 1.5% 2,706,335 +41% 0% $14,749,525
Quantinno Capital Management LP 1.5% 2,621,378 +128% 0.02% $14,286,510
AMERIPRISE FINANCIAL INC 1% 1,815,930 +20% 0% $9,896,820
NORTHERN TRUST CORP 1% 1,801,200 +4.3% 0% $9,816,540
UBS Group AG 0.97% 1,726,823 +15% 0% $9,411,186
FEDERATED HERMES, INC. 0.96% 1,704,526 +371% 0.02% $9,289,667
BANK OF AMERICA CORP /DE/ 0.89% 1,595,219 +290% 0% $8,693,943
Freestone Grove Partners LP 0.85% 1,509,954 0.06% $8,229,249
BNP PARIBAS FINANCIAL MARKETS 0.81% 1,449,886 0% 0.01% $7,901,879

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
44
Latest
Q1 2026
Rows shown
1-25 of 44
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 142,252,104 $775,659,816 +$44,606,028 $5.45 319
2025 Q4 132,196,087 $925,457,583 +$47,124,945 $7.00 337
2025 Q3 123,376,453 $953,989,710 -$44,391,699 $7.73 349
2025 Q2 127,657,050 $1,111,810,150 +$28,908,039 $8.71 348
2025 Q1 124,764,453 $993,137,558 -$13,210,237 $7.96 368
2024 Q4 126,600,183 $1,150,909,215 +$5,732,507 $9.09 366
2024 Q3 125,343,265 $1,150,235,748 -$100,725,771 $9.18 352
2024 Q2 138,653,865 $1,356,107,775 +$78,896,049 $9.78 389
2024 Q1 129,813,184 $1,959,292,768 +$8,558,227 $15.10 411
2023 Q4 128,213,716 $2,762,470,436 +$64,064,682 $21.55 425
2023 Q3 124,707,305 $2,318,095,592 -$112,449,287 $18.59 418
2023 Q2 128,734,634 $3,259,624,540 -$197,804,335 $25.32 418
2023 Q1 136,344,301 $3,528,176,976 +$69,660,076 $25.90 416
2022 Q4 134,795,560 $3,187,915,143 -$88,463,415 $23.65 419
2022 Q3 137,929,338 $3,500,590,930 -$132,587,746 $25.35 421
2022 Q2 142,508,101 $4,752,897,156 -$35,457,280 $33.21 492
2022 Q1 135,294,586 $9,760,150,727 -$44,236,110 $72.13 640
2021 Q4 135,661,577 $12,464,617,010 -$96,730,604 $91.82 689
2021 Q3 133,460,521 $16,925,944,366 +$674,213,489 $126.81 738
2021 Q2 127,751,069 $21,259,926,344 +$1,036,756,412 $166.29 807
2021 Q1 121,322,454 $22,048,095,012 +$973,044,719 $181.75 873
2020 Q4 109,175,126 $21,828,607,477 +$6,575,258,095 $199.96 869
2020 Q3 75,563,046 $16,555,972,646 +$917,790,340 $219.24 730
2020 Q2 71,460,376 $13,644,498,539 -$180,652,715 $190.84 654
2020 Q1 72,838,954 $11,295,952,445 -$2,132,897,022 $155.01 559
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .